Phase III/Seroquel SR Bipolar Depression Monotherapy - US
Public ClinicalTrials.gov record NCT00422214. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Multicenter, Double-Blind, Randomized, Parallel-Group, Placebo-Controlled, Phase III Study of the Efficacy and Safety of Quetiapine Fumarate (Seroquel SR®) Sustained-Release as Monotherapy in Adult Patients With Acute Bipolar Depression
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The purpose of this study is to determine the safety and efficacy of sustained-release quetiapine fumarate (Seroquel®) in the treatment of patients with Acute Bipolar Depression for 8 weeks. PLEASE NOTE: Seroquel SR and Seroquel XR refer to the same formulation. The SR designation was changed to XR after consultation with FDA.
Study identification
- NCT ID
- NCT00422214
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- 400 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years to 65 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Dec 2006 (Type not available)
- Primary completion
- Not listed
- Completion
- Jun 2007 (Actual)
- Last update posted
- Mar 25, 2009
2006 – 2007
United States locations
- U.S. sites
- 54
- U.S. states
- 26
- U.S. cities
- 54
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Research Site | Birmingham | Alabama | — | — |
| Research Site | Phoenix | Arizona | — | — |
| Research Site | Scottsdale | Arizona | — | — |
| Research Site | Little Rock | Arkansas | — | — |
| Research Site | Cerritos | California | — | — |
| Research Site | La Mesa | California | — | — |
| Research Site | Los Angeles | California | — | — |
| Research Site | Newport Beach | California | — | — |
| Research Site | Northridge | California | — | — |
| Research Site | Oceanside | California | — | — |
| Research Site | Pico Rivera | California | — | — |
| Research Site | San Diego | California | — | — |
| Research Site | Wildomar | California | — | — |
| Research Site | Washington D.C. | District of Columbia | — | — |
| Research Site | Bradenton | Florida | — | — |
| Research Site | Fort Lauderdale | Florida | — | — |
| Research Site | Jacksonville | Florida | — | — |
| Research Site | Leesburg | Florida | — | — |
| Research Site | Maitland | Florida | — | — |
| Research Site | North Miami | Florida | — | — |
| Research Site | Orlando | Florida | — | — |
| Research Site | Tampa | Florida | — | — |
| Research Site | West Palm Beach | Florida | — | — |
| Research Site | Smyrna | Georgia | — | — |
| Research Site | Honolulu | Hawaii | — | — |
| Research Site | Joliet | Illinois | — | — |
| Research Site | Greenwood | Indiana | — | — |
| Research Site | Indianapolis | Indiana | — | — |
| Research Site | Wichita | Kansas | — | — |
| Research Site | Shreveport | Louisiana | — | — |
| Research Site | Rockville | Maryland | — | — |
| Research Site | Farmington Hills | Michigan | — | — |
| Research Site | St Louis | Missouri | — | — |
| Research Site | Cherry Hill | New Jersey | — | — |
| Research Site | Clementon | New Jersey | — | — |
| Research Site | Brooklyn | New York | — | — |
| Research Site | New York | New York | — | — |
| Research Site | Staten Island | New York | — | — |
| Research Site | Beachwood | Ohio | — | — |
| Research Site | Cincinnati | Ohio | — | — |
| Research Site | Dayton | Ohio | — | — |
| Research Site | Oklahoma City | Oklahoma | — | — |
| Research Site | Portland | Oregon | — | — |
| Research Site | Salem | Oregon | — | — |
| Research Site | Philadelphia | Pennsylvania | — | — |
| Research Site | Charleston | South Carolina | — | — |
| Research Site | Memphis | Tennessee | — | — |
| Research Site | Dallas | Texas | — | — |
| Research Site | Houston | Texas | — | — |
| Research Site | Charlottesville | Virginia | — | — |
| Research Site | Virginia Beach | Virginia | — | — |
| Research Site | Bellevue | Washington | — | — |
| Research Site | Seattle | Washington | — | — |
| Research Site | South Kirkland | Washington | — | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00422214, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Mar 25, 2009 · Synced Oct 21, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT00422214 live on ClinicalTrials.gov.